Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
IJID Regions|June 20, 2022
SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021Avula Laxmaiah, Nalam Madhusudhan Rao, N Arlappa, et al.
BMJ Open|July 28, 2022
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020Kathiresan Jeyashree, Jeromie Thangaraj, Kiran Rade, et al.
The Lancet Regional Health. Southeast Asia|September 4, 2023
Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016-22Pradeep Kumar Gunasekaran, Devika Shanmugasundaram, Sridhar Santhanam, et al.
The Lancet Regional Health. Southeast Asia|June 11, 2025
Neuromelioidosis outbreak in Tamil Nadu, India: an investigation of transmission with genomic insightsAngel Miraclin Thirugnanakumar, Prabu Rajkumar, Karthik Gunasekaran, et al.
Vaccine|July 3, 2024
Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022Devika Shanmugasundaram, Rajlakshmi Viswanathan, Amy K Winter, et al.
Heliyon|May 30, 2023
Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance dataDevika Shanmugasundaram, Sanjay Verma, Kuldeep Singh, et al.
The Lancet Regional Health. Southeast Asia|June 15, 2026
Pneumococcal meningitis among hospitalised children after introduction of pneumococcal conjugate vaccine in India: a sentinel hospital surveillance (2019-2022)Girish Kumar Chethrapilly Purushothaman, Prabu Rajkumar, Boopathi Kangusamy, et al.
Plos One|August 8, 2022
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, IndiaManickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Plos One|April 4, 2025
Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, IndiaManickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
Pageof 9